Stock Traders Purchase Large Volume of Amedisys Put Options (NASDAQ:AMED)

Amedisys, Inc. (NASDAQ:AMED) was the target of some unusual options trading activity on Friday. Stock investors bought 3,269 put options on the stock. This represents an increase of approximately 136% compared to the typical volume of 1,385 put options.

Hedge Funds Weigh In On Amedisys

Institutional investors and hedge funds have recently modified their holdings of the stock. Innealta Capital LLC acquired a new stake in Amedisys during the second quarter valued at $64,000. Signaturefd LLC increased its holdings in Amedisys by 88.2% in the second quarter. Signaturefd LLC now owns 1,131 shares of the health services provider’s stock worth $104,000 after buying an additional 530 shares during the last quarter. Commonwealth Equity Services LLC raised its position in Amedisys by 10.9% during the second quarter. Commonwealth Equity Services LLC now owns 4,151 shares of the health services provider’s stock valued at $381,000 after acquiring an additional 409 shares in the last quarter. Versor Investments LP lifted its stake in Amedisys by 23.5% in the second quarter. Versor Investments LP now owns 6,721 shares of the health services provider’s stock valued at $617,000 after acquiring an additional 1,279 shares during the last quarter. Finally, Privium Fund Management UK Ltd bought a new stake in Amedisys in the second quarter worth approximately $1,284,000. 94.36% of the stock is currently owned by hedge funds and other institutional investors.

Amedisys Stock Up 4.3 %

Shares of AMED traded up $3.68 during mid-day trading on Friday, reaching $89.63. The company’s stock had a trading volume of 839,192 shares, compared to its average volume of 385,003. The company has a market cap of $2.94 billion, a price-to-earnings ratio of 35.57, a price-to-earnings-growth ratio of 1.84 and a beta of 0.73. Amedisys has a 1 year low of $82.15 and a 1 year high of $98.95. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. The business has a fifty day moving average of $90.60 and a 200 day moving average of $94.44.

Amedisys (NASDAQ:AMED) last issued its earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19). Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The business had revenue of $587.67 million during the quarter, compared to analyst estimates of $586.75 million. During the same quarter in the prior year, the company earned $0.98 EPS. Amedisys’s revenue for the quarter was up 5.7% on a year-over-year basis. As a group, analysts forecast that Amedisys will post 4.45 earnings per share for the current fiscal year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.